BridgeBio Pharma, Inc. — All Filings
755 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-Q
144
3
4
4/A
424B3
424B4
424B5
424B7
425
5
5/A
8-A12B
8-K
ARS
CERT
CORRESP
CT ORDER
DEF 14A
DEFA14A
DEFM14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
S-1
S-1/A
S-1MEF
S-3ASR
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-000828 | Mar 26, 2026 | — |
| 4 | FORM 4 | 0001470831-26-000304 | Mar 20, 2026 | Mar 18, 2026 |
| 4 | FORM 4 | 0001470831-26-000302 | Mar 20, 2026 | Mar 18, 2026 |
| 4 | FORM 4 | 0001470831-26-000296 | Mar 19, 2026 | Mar 17, 2026 |
| 4 | FORM 4 | 0001470831-26-000275 | Mar 16, 2026 | Mar 12, 2026 |
| 144 | — | 0001950047-26-002594 | Mar 13, 2026 | — |
| 4 | FORM 4 | 0001470831-26-000260 | Mar 12, 2026 | Mar 10, 2026 |
| 144 | — | 0001950047-26-002400 | Mar 10, 2026 | — |
| 4 | FORM 4 | 0001470831-26-000252 | Mar 6, 2026 | Mar 4, 2026 |
| 144 | — | 0001950047-26-002147 | Mar 4, 2026 | — |
| 4 | FORM 4 | 0001470831-26-000236 | Mar 3, 2026 | Feb 27, 2026 |
| 144 | — | 0001950047-26-001893 | Feb 27, 2026 | — |
| 4 | FORM 4 | 0001470831-26-000225 | Feb 27, 2026 | Feb 26, 2026 |
| 10-K | 10-K | 0001743881-26-000009 | Feb 24, 2026 | Dec 31, 2025 |
| 8-K | 8-K | 0001743881-26-000008 | Feb 24, 2026 | — |
| 4 | FORM 4 | 0001470831-26-000214 | Feb 23, 2026 | Feb 19, 2026 |
| 144 | — | 0001950047-26-001512 | Feb 19, 2026 | — |
| 4 | FORM 4 | 0001470831-26-000188 | Feb 18, 2026 | Feb 16, 2026 |
| 4 | FORM 4 | 0001470831-26-000186 | Feb 18, 2026 | Feb 16, 2026 |
| 4 | FORM 4 | 0001470831-26-000184 | Feb 18, 2026 | Feb 16, 2026 |
| 4 | FORM 4 | 0001470831-26-000182 | Feb 18, 2026 | Feb 17, 2026 |
| SCHEDULE 13D/A | — | 0000905148-26-000914 | Feb 17, 2026 | — |
| 144 | — | 0001950047-26-001375 | Feb 17, 2026 | — |
| 144 | — | 0001950047-26-001308 | Feb 17, 2026 | — |
| 4 | FORM 4 | 0001470831-26-000118 | Feb 12, 2026 | Feb 10, 2026 |
| 8-K | 8-K | 0001140361-26-004995 | Feb 12, 2026 | — |
| 8-K | 8-K | 0001140361-26-001843 | Jan 21, 2026 | Jan 14, 2026 |
| 4 | FORM 4 | 0001470831-26-000026 | Jan 12, 2026 | Jan 8, 2026 |
| 8-K | 8-K | 0001140361-26-000971 | Jan 12, 2026 | — |
| 144 | — | 0001950047-26-000276 | Jan 8, 2026 | — |
| 144 | — | 0001950047-26-000275 | Jan 8, 2026 | — |
| 4 | FORM 4 | 0001470831-25-000422 | Dec 16, 2025 | Dec 12, 2025 |
| 4 | FORM 4 | 0001470831-25-000420 | Dec 16, 2025 | Dec 12, 2025 |
| 4 | FORM 4 | 0001470831-25-000418 | Dec 16, 2025 | Dec 12, 2025 |
| 144 | — | 0001950047-25-010321 | Dec 15, 2025 | — |
| 4 | FORM 4 | 0001470831-25-000392 | Dec 10, 2025 | Dec 8, 2025 |
| 4 | FORM 4 | 0001470831-25-000386 | Dec 8, 2025 | Dec 4, 2025 |
| 4 | FORM 4 | 0001470831-25-000366 | Nov 24, 2025 | Nov 20, 2025 |
| 144 | — | 0001950047-25-009146 | Nov 20, 2025 | — |
| 4 | FORM 4 | 0001470831-25-000357 | Nov 19, 2025 | Nov 17, 2025 |
| 4 | FORM 4 | 0001470831-25-000355 | Nov 19, 2025 | Nov 17, 2025 |
| 4 | FORM 4 | 0001470831-25-000353 | Nov 18, 2025 | Nov 16, 2025 |
| 4 | FORM 4 | 0001470831-25-000351 | Nov 18, 2025 | Nov 16, 2025 |
| 4 | FORM 4 | 0001470831-25-000349 | Nov 18, 2025 | Nov 16, 2025 |
| 144 | — | 0001950047-25-009007 | Nov 18, 2025 | — |
| 144 | — | 0001950047-25-008990 | Nov 17, 2025 | — |
| 144 | — | 0001950047-25-008947 | Nov 17, 2025 | — |
| 144 | — | 0001950047-25-008929 | Nov 17, 2025 | — |
| SCHEDULE 13D/A | — | 0000905148-25-004059 | Nov 14, 2025 | — |
| 4 | FORM 4 | 0001470831-25-000317 | Nov 14, 2025 | Nov 12, 2025 |